COVID-19: FG To Arraign Owners Of Supermarkets, Pharmacies Over Price Hike

Man Bags 15 Years In Prison For N5.2m Fraud


A Federal High Court sitting in Abuja has fixed June 25 for the arraignment of owners of two supermarkets and two pharmacies charged for hiking prices of key hygiene products such as hand sanitizers and face masks.

The companies were dragged to court by the Federal Competition and Consumer Protection Council (FCCPC) for allegedly taking undue advantage of the COVID-19 pandemic to inflate prices of key hygiene products contrary to Section 108(1) of FCCP Act 2018.

However, when the matter was called, the prosecution counsel, Babatunde Irukere, told the court that the matter was for arraignment and that they were ready for the matter as scheduled.

But Counsel to the first and second defendants (H-Medics and Sandra Ejekwe), Abubakar Mohammed, announced that the second defendant could not appear in court as she was not served with the court notice.

In a similar suit involving Bakan Gizo Pharmacy and Store, Ray Opia and Luter Irene, the defense counsel, Festus Okpe, informed the court that the second defendant, who has been in Lagos since January was restricted from appearing in court due to the ban on interstate travel.

Other defendants in the suit are Prince Ebeano Super Market and David Chukwuma who sent an electronic communication explaining their reasons for being absent in court.

In his explanation, Mr Chukwuma blamed his inability to appear in court on the ban on interstate movement by the Federal Government due to the COVID-19.

The presiding judge, Justice Nkonye Maha, had earlier raised the issue of jurisdiction, stressing that the matter ought to have been taken to the tribunal.

The judge, however, settled down to hear the matter after the issue was cleared.

After due consideration, the judge adjourned the matter till June 25.

She, however, ordered that all parties to the matter be served with notices to ensure they are all in court on the next adjourned date.

Some of the charges are: “That you, H-Medix Pharmacy &Sons Ltd, Sandra Ejekwu(f) and John Oluwagbemiga (m) at various times between the 28th day of February 2020 and the 6th day of March 2020, at H-Medix Pharmacy & Sores Ltd, 43 Ademola Adetokumbo crescent, Wuse 11, Abuja and other retail trading outlets of H-Medix Pharmacy and stores Ltd, within the jurisdiction of this Honorable Court, did engage in making false, misleading, deceptive representation in relation to the price of sanitizers, hand-wash liquids and disinfectants of various existing brands on display at your retail outlets and thereby committed an offence contrary to Sector 125(1) (a) of the federal competition and consumer protection Act, 2018 and punishable under Section 155 of the Federal Competition and Consumer Protection Act, 2018.

“That you, Prince Eleanor Supermarket Ltd and David Chukwuma Ojei (m) at various times between the 28th day of February 2020 and the 6th day of March 2020, at Prince Eleanor Supermarket Ltd, Plot 551, Abdusalam Abubakar Way, Gaduwa, Lokogoma Junction, Abuja and other retail trading outlets of Prince Eleanor Supermarket Ltd, within the jurisdiction of this honourable court, did conspire, combine, agree and arrange to unreasonably enhance the price of sanitizers, hand wash liquids and disinfectants of various existing brands and thereby committed an offense contrary to Section 108(1) (b) of the federal competition and consumer protection Act, 2018 and punishable under Section 108(4) of the federal competition and consumer protection Act, 2018.”

US Pharmacies Authorised To Test For COVID-19


The US authorized pharmacies on Wednesday to carry out tests for the coronavirus, including newly developed antibody tests that detect whether a person who has recovered from illness had COVID-19.

Health secretary Alex Azar, announced that all tests approved by regulators could be carried out by pharmacies as the country seeks to ramp up its testing efforts.

“The Trump Administration is pleased to give pharmacists the chance to play a bigger role in the COVID-19 response, alongside all of America’s heroic healthcare workers,” he said.

A nasal swab test can detect whether a person currently has the coronavirus.

After they have recovered, a test that looks at whether their body developed antibodies that fought off the virus and can be used — even if the person never showed symptoms.

There are different kinds of antibody tests and they can’t yet tell whether a person has sufficient antibodies to be protected against future infection.

A Chinese study posted this week, but not yet peer reviewed, showed that some former patients had relatively low levels of antibodies in the blood.

In Washington on Wednesday, a private medical center announced that it was offering a 15-minute serology test, at a cost of $290.


Brazil Approves Sale Of Medical Cannabis In Pharmacies

AFP Photo


Brazil’s health watchdog on Tuesday approved the sale of cannabis-based products for medical use in pharmacies to people with a prescription.

The regulation, which takes effect in the coming months, also allows for the manufacture of such products in a laboratory, the Brazilian Health Regulatory Agency (Anvisa) said in a statement.

Anvisa is analyzing the possibility of permitting the cultivation of medical cannabis.

READ ALSO: Prince Andrew’s Accuser Slams ‘Ridiculous Excuses’

In recent years, several countries in Latin America have legalized cannabis for medical use, including Uruguay, Chile, Colombia, Argentina, Mexico and Peru.

President Jair Bolsonaro has previously expressed support for medical cannabis. But the ultraconservative leader would “not permit loopholes in the law to be used for the planting and consumption of marijuana,” his spokesman Otavio Rego Barros told reporters in August.

Since 2015, Anvisa has allowed people with a medical prescription to import cannabidiol, or CBD, a non-psychoactive marijuana derivative, for the treatment of epilepsy and chronic illnesses.

The new regulation allows for the sale of products with a concentration of tetrahydrocannabinol, or THC — the main psychoactive constituent responsible for marijuana’s intoxicating effects — of more than 0.2 percent to terminally ill patients or those who have exhausted alternative treatment options.

Others will be allowed to buy medical cannabis products with a THC concentration of less than 0.2 percent.